A gene therapy ointment to reverse neuropathy
In a study just published in Molecular Pain, Northwestern Medicine researchers showed that depleting GM3 through genetic modification prevented the development of neuropathy.
The researchers apply a gene therapy ointment to deplete GM3 and GM3 synthase. Thus far, this GM3-depleting ointment, applied just to the plantar surface of a diabetic’s feet will prevent or reverse the existing neuropathy. The study is available FREE:
Ganglioside GM3 synthase depletion reverses neuropathic pain and small fiber neuropathy in diet-induced diabetic mice.
- Comments (1)